Detalhe da pesquisa
1.
Patient-reported treatment response in chronic graft-versus-host disease.
Haematologica
; 109(1): 143-150, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226713
2.
Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.
Pediatr Blood Cancer
; 66(1): e27421, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151986
3.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant
; 24(2): 373-380, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051021
4.
Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH).
PLoS One
; 19(5): e0298026, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753616
5.
Clinical benefit of response in chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(10): 1517-24, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683612
6.
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(11): 1649-55, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22691695
7.
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Biol Blood Marrow Transplant
; 12(4): 375-96, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16545722
8.
Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 12(7): 792-4, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785070